Category: Brandpoint Health

2024-11-02T06:01:00

(BPT) – In the United States alone, about 38.4 million people have diabetes. That’s about 11.6% of the population. November is National Diabetes Month, which serves as an important reminder to not only rally around those affected by this disease, but also take steps in our own lives to help manage it. It’s the perfect time to provide extra support to loved ones who have this disease and, if you have diabetes yourself, implement healthy lifestyle habits to stay on track of your health goals.

Here are our top tips:

• Eat balanced meals: Understanding which foods affect your blood sugar levels can help you properly plan your meals.
• Exercise: Moving your body can help lower your blood sugar levels, so work with your doctor to come up with an exercise routine that works for you.
• Prevent illness: Being sick can raise your blood sugar levels. That’s why it’s important to avoid illness if possible and create a plan with your doctor for what to do if you do get sick.
• Get vaccinated against pneumococcal pneumonia and invasive pneumococcal disease (IPD): Know your risk and help protect yourself.

It’s important to know that having diabetes can put you at increased risk for illnesses like pneumococcal pneumonia and IPD. Pneumococcal pneumonia is a potentially serious bacterial lung disease that can disrupt your life for weeks, put you in the hospital and even be life-threatening. The same bacteria that cause pneumococcal pneumonia are also responsible for invasive pneumococcal disease, or IPD, which includes blood infection and meningitis.

How do you know if you’re at risk? If you’re 19 or older with certain underlying medical conditions like diabetes, asthma, chronic heart disease and COPD, you’re at increased risk for both of these diseases. In fact, people aged 19-64 living with diabetes are at over 5x higher risk for pneumococcal pneumonia and up to 4.8x higher risk for IPD, compared with healthy adults the same age. Adults 65 or older are also at increased risk, even if they’re healthy.

If you fit in any of these groups, getting vaccinated is one of the best ways to help protect yourself.

There’s a misconception that you can only get pneumococcal pneumonia and IPD during flu season or in the winter, but you can get it any time of year. Vaccination is available all year round, so now is a great time to assess if pneumococcal vaccination is right for you.

Even if you’ve already been vaccinated against pneumococcal pneumonia previously, your healthcare provider may recommend another vaccination for additional protection.

If you have diabetes, take the time this month to assess how you’re managing it and make sure you’re helping protect yourself. Not sure where to start? Talk to your doctor or pharmacist about pneumococcal vaccination and visit VaxAssist.com to schedule a vaccination appointment today.

Brought to you by Pfizer.

2024-11-01T08:15:00

(BPT) – When she was a full-time college student, Tara was also pretty busy with two part-time jobs working in healthcare, being a dog mom, and spending time with her two nephews and her niece. Her schedule was jam-packed. Tara described feeling like she was “tired all the time” and just wanted to sleep. “It would be so hard to get up and go to work and stay awake at work,” she shared. Tara didn’t know at the time, but she was experiencing a symptom of narcolepsy called excessive daytime sleepiness (EDS).

Narcolepsy is a rare neurological disorder that affects approximately 170,000 people living in the United States. All people living with narcolepsy have EDS, which is defined as the inability to stay awake and alert during the day or the persistent feeling of tiredness. Tara’s relationships with friends and family, daily life, and work were all impacted by EDS. “There’s unfortunately a societal misconception that people living with narcolepsy lack motivation to do things, are lazy, or are depressed,” noted Ellen Wermter, FNP-BC, a sleep medicine specialist at Restorative Sleep Medicine in Charlottesville, VA. For Tara, she shared, “Simple things like cooking, showering, hanging out with friends—they were all impacted by the excessive daytime sleepiness. I dreaded doing almost anything. I just wanted to sleep.”

In addition to excessive daytime sleepiness, Tara would often drop things or randomly fall. She dismissed these signs, thinking she was just being clumsy, but she was actually experiencing another narcolepsy symptom called cataplexy. Cataplexy is defined as the sudden onset of weak or paralyzed muscles, usually brought on by strong emotions or certain situations. It can cause the person’s knees to buckle or collapse completely; but more often it affects specific areas of the body such as the hands or eyelids. Wermter noted, “In my experience, many people may not realize that what they are experiencing is cataplexy and that it is related to their narcolepsy.”

When Tara first received her diagnosis of narcolepsy with cataplexy, part of her was relieved knowing it “actually was something and wasn’t just in [her] head.” With that sense of relief, Tara also felt a little nervous not knowing what was next.

Searching for a treatment

Tara first learned about WAKIX^® (pitolisant) after someone mentioned it in an online support group, and she also saw it on social media. What interested Tara most about WAKIX was that it wasn’t a controlled substance.

“WAKIX is FDA approved to treat excessive daytime sleepiness (EDS) or cataplexy in adults with narcolepsy and to treat EDS in children 6 years of age and older with narcolepsy,” explained Wermter. “It is also the first and only FDA-approved treatment for people with narcolepsy that is not a controlled substance,” she added. A controlled substance is defined as a drug or chemical that is regulated by the government based on its potential for abuse and dependence. “In a clinical study in adults, WAKIX did not show potential for abuse, similar to placebo, which is also known as a sugar pill,” Wermter further explained.

Tara asked her healthcare provider about WAKIX, and they had discussions that led to her starting WAKIX in 2020.

Partnering with your healthcare provider

When Tara began discussions with her healthcare provider about starting WAKIX, he mentioned that there would be a titration period where they start out with a lower dose and then work up to find the dose that was right for her. They also discussed expectations from treatment and possible side effects with WAKIX.

When starting a new medication, it’s important to talk with your healthcare provider so they can help you understand what to expect. “When I start a new patient on WAKIX, I tell them it‘s important to be in communication and be honest about how they’re feeling. I explain that we’ll start at a lower dose and then will increase the dose for the next two to three weeks until we find the dose that is right for them,” Wermter explained. “I want my patients to understand that everyone responds to medications differently, and for some patients it may take up to 8 weeks to achieve a clinical response. As such, it’s important they give WAKIX a chance to work.”

Tara started to notice that WAKIX was working when her friends and family noticed that she had more wakefulness. “They were excited for me,” she shared. “To have that kind of support around me felt reassuring that I wasn’t all alone.”

Finding support is important

An important aspect of navigating life with narcolepsy is the support from others. Tara found this through online support groups with others living with narcolepsy and felt that this is something that helped her in navigating through day-to-day life with narcolepsy. Since her diagnosis, Tara has been an active advocate in the narcolepsy community. “It’s important to me to be an advocate in the narcolepsy community and share my personal story because I want to help others know that they’re not alone and helpful resources are available,” Tara explained.

If you or someone you know is living with narcolepsy, speak with a healthcare provider to see if WAKIX could be an option. Read more about WAKIX below. To see videos about the experiences of Tara and others living with narcolepsy who are taking WAKIX, visit WAKIX Personal Stories.

Indications and Usage

WAKIX is a prescription medicine used to treat:
• excessive daytime sleepiness (EDS) or cataplexy in adults with narcolepsy.
• excessive daytime sleepiness (EDS) in children 6 years of age and older with narcolepsy.

Important Safety Information

Do not take WAKIX if you are allergic to pitolisant or any ingredient in WAKIX, or if you have severe liver disease.

WAKIX can cause a change in the electrical activity of the heart known as QT prolongation. This is a heart rhythm problem that can lead to an abnormal heartbeat. You have a higher chance of getting QT prolongation if you have certain heart or other medical conditions, or if you take WAKIX with certain medicines. Tell your healthcare provider right away if you have a change in your heartbeat or if you feel dizzy or faint while taking WAKIX.

Tell your healthcare provider about all your medical conditions, including if you have any heart, liver, or kidney problems, or problems with blood levels of your electrolytes, such as potassium or magnesium.

Tell your healthcare provider about all the medicines you take or plan to take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Taking WAKIX with certain medicines may cause side effects or affect the way each other works.

Hormonal birth control methods may not work while taking WAKIX. Use an alternative non-hormonal birth control method during treatment with WAKIX and for at least 21 days after stopping WAKIX.

Tell your healthcare provider if you are pregnant or planning to become pregnant. You are encouraged to enroll in the WAKIX pregnancy registry if you become pregnant while taking WAKIX. The registry collects information about the health of you and your baby. To enroll or obtain information from the registry, call 1-800-833-7460.

The most common side effects of WAKIX in adults include insomnia, nausea, and anxiety. The most common side effects of WAKIX in children include headache and insomnia. These are not all the possible side effects of WAKIX. Call your healthcare provider for medical advice about side effects.

It is not known if WAKIX is safe and effective to treat excessive daytime sleepiness in children under 6 years of age with narcolepsy or to treat cataplexy in people under 18 years of age with narcolepsy.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088. You can also report negative side effects to Harmony Biosciences at 1-800-833-7460.

Please see accompanying Full Prescribing Information.

WAKIX is a registered trademark of Bioprojet Europe, Ltd.
Harmony Biosciences name and logo are registered trademarks.
© 2024 Harmony Biosciences. All rights reserved.
US-WAK-2400684/Oct 2024

2024-10-31T08:59:00

(BPT) – Respiratory illness season has officially begun. As the holidays approach and many spend more time indoors with loved ones, the risk of contracting common respiratory illnesses like flu, COVID-19, pneumonia and RSV will rise.

But germs aren’t the only things spreading this fall and winter; many vaccine-related myths and misinformation are also circulating and posing a risk to the health and safety of communities. Here are four common myths to look out for this season:

• Myth #1: I’m healthy, so I don’t need to get vaccinated. This is false. Vaccines are a safe and dependable way to help build immunity even in healthy individuals. Vaccines are the number one way to protect against respiratory illnesses and reduce the severity of symptoms if you do get sick. This time of year can be busy, but it’s critical that everyone takes the time to get their annual flu shot, updated COVID-19 vaccine, and other CDC-recommended immunizations, like RSV and pneumonia (pneumococcal). Getting vaccinated also reduces the chances that you’ll spread respiratory illnesses to people who are at higher risk of developing severe complications.

• Myth #2: It’s too late to get vaccinated. If you haven’t gotten the flu, COVID-19 or RSV vaccine, it’s not too late. However, you should get your recommended vaccines as soon as possible, especially before you travel or gather this holiday season to allow time for immunity to fully develop and increase your protection. Walgreens makes it simple to get all the recommended vaccines you need in one visit. To schedule a vaccination appointment in English or Spanish, use the Walgreens app, visit Walgreens.com/ScheduleVaccine or call 1-800-WALGREENS. We offer flexible openings, including nights and weekends, and walk-ins are welcome.

• Myth #3: I won’t be able to afford my vaccinations. The flu shot and other recommended vaccines are covered by most insurance plans, and for those who are uninsured, Walgreens offers 200,000 flu shot vouchers annually to provide free flu immunizations for medically underserved populations that need them most. Vouchers are available in-store and at clinics operated by Walgreens off-site, while supplies last. Talk to your local pharmacist about voucher availability in your area. This voucher program is part of a broader effort by Walgreens to help ensure underserved and at-risk communities stay safe from respiratory illnesses while improving awareness, access and equity to vaccines.

• Myth #4: I have mild symptoms, so I don’t need to get tested for flu or COVID-19. Flu and COVID-19 have similar symptoms to the common cold or other respiratory illnesses. Individuals who are experiencing a runny nose, cough or other respiratory symptoms should consider getting tested to know with greater confidence which virus they may have and before traveling or gathering with loved ones. This ensures individuals can quickly take the necessary steps toward recovery and avoid spreading illnesses to people at higher risk for complications. Walgreens offers a variety of convenient, low-cost options for flu and COVID-19 testing, including an easy combination test for COVID-19 and influenza A/B with results in 30 minutes or less, for $24.99. At-home tests, along with over-the-counter medicine cabinet essentials, are available for delivery in as little as 1 hour. And, if you are sick or just looking for affordable, convenient home delivery, Walgreens offers Same Day Prescription Delivery for $5.99 at more than 8,000 Walgreens with no membership required.

Walgreens: Your partner in health

Walgreens is your one-stop resource for all your immunization, testing and treatment needs this holiday season. If you have any questions, our expert pharmacists are here to help navigate the latest vaccination guidance and what is recommended for you and your loved ones.

Schedule your vaccine now at Walgreens.com/ScheduleVaccine.

2024-10-28T07:01:00

(BPT) – This article is sponsored by SK Life Science, Inc.

Epilepsy is a neurological disorder that affects over 3 million Americans, and remains misunderstood by many. Characterized by unpredictable seizures, it can have a profound impact on a person’s day-to-day activities, relationships, and mental health. Yet, with increased awareness, education, and access to proper treatment, those living with epilepsy can work toward a life with fewer seizures.

This November, as the nation observes National Epilepsy Awareness Month, it’s an important opportunity to shed light on this often-misunderstood condition and advocate for better care and support for the epilepsy community.

Why Epilepsy Awareness Matters

Despite its prevalence, many misconceptions about epilepsy persist. Seizures, which vary widely in type and severity, are not always easy to identify, and the causes of epilepsy can be complex, ranging from genetics to brain injury. Public awareness campaigns during National Epilepsy Awareness Month aim to dispel myths, highlight the realities of living with epilepsy, and encourage people to learn more about seizure first aid.

Educating the public is crucial, not only to improve the lives of those with epilepsy but also to foster an understanding community. When those around them—family, friends, coworkers—know how to respond to a seizure, it can lead to faster intervention and a stronger support system for the person experiencing the seizure.

Striving for Better Outcomes

While living with epilepsy presents challenges, many people are unaware of the progress in seizure management and treatment options. Seizure control has come a long way in recent years, with advances in medications and individualized treatment plans offering hope to many who may have felt they had few options.

One key step for patients is working closely with a doctor, often an epileptologist or neurologist, to find the right treatment plan for their specific condition. Epileptologists are experts in managing epilepsy and can help patients explore the latest therapies designed to target uncontrolled seizures, empowering them to regain control of their lives.

The Path to Seizure Reduction

National Epilepsy Awareness Month highlights the important goal shared by many patients and doctors: reducing the frequency and impact of seizures. While eliminating seizures entirely may not always be possible, today’s treatments offer promising outcomes. It’s essential for individuals with epilepsy to consult regularly with their healthcare providers to evaluate and adjust their treatment plans to achieve the best possible seizure reduction.

One such treatment option is XCOPRI^® (cenobamate tablets) CV, a prescription medication approved for the treatment of partial-onset seizures in adults 18 and older, which has been shown to reduce the frequency of seizures in some patients. If you or a loved one struggles with uncontrolled seizures, consider discussing treatment options like XCOPRI with your doctor.

Like any medication, XCOPRI has risks and benefits. Do not take XCOPRI if you are allergic to it or have a genetic problem (called familial short QT syndrome) that affects the electrical system of the heart. XCOPRI can have serious side effects including serious allergic reaction which may affect organs and other parts of your body like the liver or blood cells. XCOPRI may cause problems with the electrical system of the heart (QT shortening). Antiseizure drugs, including XCOPRI, may cause suicidal thoughts or actions in a very small number of people, about 1 in 500. Call your doctor right away if you have suicidal thoughts or actions, or new or worsening depression, anxiety, or irritability. XCOPRI may cause problems that affect your nervous system, including dizziness, trouble walking or with coordination, feeling sleepy and tired, trouble concentrating, remembering and thinking clearly, and vision problems. Do not drive, operate heavy machinery, or do other dangerous activities until you know how XCOPRI affects you.

These are not all of XCOPRI’s side effects. We encourage you to read the Important Safety Information included at the end of this article. Before considering XCOPRI^®, it is vital to consult with your healthcare provider to determine if it is suitable for your specific needs. For more information, please visit www.xcopri.com.

How You Can Help

Whether you live with epilepsy or want to support someone who does, there are many ways to get involved during National Epilepsy Awareness Month. Take time to learn about seizure first aid, advocate for increased research funding, or raise awareness in your community or online. Every action brings us closer to a world where individuals living with epilepsy can experience better seizure management and thrive with greater confidence and support.

IMPORTANT SAFETY INFORMATION and INDICATION for XCOPRI^® (cenobamate tablets) CV

DO NOT TAKE XCOPRI IF YOU:

• Are allergic to cenobamate or any of the other ingredients in XCOPRI.
• Have a genetic problem (called Familial Short QT syndrome) that affects the electrical system of the heart.

XCOPRI CAN CAUSE SERIOUS SIDE EFFECTS, INCLUDING:

Allergic reactions: XCOPRI can cause serious skin rash or other serious allergic reactions which may affect organs and other parts of your body like the liver or blood cells. You may or may not have a rash with these types of reactions. Call your healthcare provider right away and go to the nearest emergency room if you have any of the following: swelling of your face, eyes, lips, or tongue, trouble swallowing or breathing, a skin rash, hives, fever, swollen glands, or sore throat that does not go away or comes and goes, painful sores in the mouth or around your eyes, yellowing of your skin or eyes, unusual bruising or bleeding, severe fatigue or weakness, severe muscle pain, frequent infections, or infections that do not go away. Take XCOPRI exactly as your healthcare provider tells you to take it. It is very important to increase your dose of XCOPRI slowly, as instructed by your healthcare provider.

QT shortening: XCOPRI may cause problems with the electrical system of the heart (QT shortening). Call your healthcare provider if you have symptoms of QT shortening including fast heartbeat (heart palpitations) that last a long time or fainting.

Suicidal behavior and ideation: Antiepileptic drugs, including XCOPRI, may cause suicidal thoughts or actions in a very small number of people, about 1 in 500. Call your health care provider right away if you have any of the following symptoms, especially if they are new, worse, or worry you: thoughts about suicide or dying; attempting to commit suicide; new or worse depression, anxiety, or irritability; feeling agitated or restless; panic attacks; trouble sleeping (insomnia); acting aggressive; being angry or violent; acting on dangerous impulses; an extreme increase in activity and talking (mania); or other unusual changes in behavior or mood.

Nervous system problems: XCOPRI may cause problems that affect your nervous system. Symptoms of nervous system problems include: dizziness, trouble walking or with coordination, feeling sleepy and tired, trouble concentrating, remembering, and thinking clearly, and vision problems. Do not drive, operate heavy machinery, or do other dangerous activities until you know how XCOPRI affects you.

Do not drink alcohol or take other medicines that can make you sleepy or dizzy while taking XCOPRI without first talking to your healthcare provider.

DISCONTINUATION:

Do not stop taking XCOPRI without first talking to your healthcare provider. Stopping XCOPRI suddenly can cause serious problems. Stopping seizure medicine suddenly in a patient who has epilepsy can cause seizures that will not stop (status epilepticus).

DRUG INTERACTIONS:

XCOPRI may affect the way other medicines work, and other medicines may affect how XCOPRI works. Do not start or stop other medicines without talking to your healthcare provider. Tell healthcare providers about all the medicines you take, including prescription and over-the-counter medicines, vitamins and herbal supplements.

PREGNANCY AND LACTATION:

XCOPRI may cause your birth control medicine to be less effective. Talk to your health care provider about the best birth control method to use.

Talk to your health care provider if you are pregnant or plan to become pregnant. It is not known if XCOPRI will harm your unborn baby. Tell your healthcare provider right away if you become pregnant while taking XCOPRI. You and your healthcare provider will decide if you should take XCOPRI while you are pregnant. If you become pregnant while taking XCOPRI, talk to your healthcare provider about registering with the North American Antiepileptic Drug (NAAED) Pregnancy Registry. The purpose of this registry is to collect information about the safety of antiepileptic medicine during pregnancy. You can enroll in this registry by calling 1-888-233-2334 or go to www.aedpregnancyregistry.org.

Talk to your health care provider if you are breastfeeding or plan to breastfeed. It is not known if XCOPRI passes into breastmilk. Talk to your healthcare provider about the best way to feed your baby while taking XCOPRI.

COMMON SIDE EFFECTS:

The most common side effects in patients taking XCOPRI include dizziness, sleepiness, headache, double vision, and feeling tired.

These are not all the possible side effects of XCOPRI. Tell your healthcare provider if you have any side effect that bothers you or that does not go away. For more information, ask your healthcare provider or pharmacist. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088 or at www.fda.gov/medwatch.

DRUG ABUSE:

XCOPRI is a federally controlled substance (CV) because it can be abused or lead to dependence. Keep XCOPRI in a safe place to prevent misuse and abuse. Selling or giving away XCOPRI may harm others and is against the law.

INDICATION:

XCOPRI is a prescription medicine used to treat partial-onset seizures in adults 18 years of age and older.

It is not known if XCOPRI is safe and effective in children under 18 years of age.

Please see additional patient information in the Medication Guide. This information does not take the place of talking with your healthcare provider about your condition or your treatment.

Please see full Prescribing Information and Medication Guide.

2024-10-23T16:25:00

(BPT) – If you’re an American over age 65, or have a senior loved one, you know how big of a risk falls can be in daily life. As people age, their balance becomes less steady, which can lead to an increase in stumbles and tumbles. But it can mean more than the inconvenience of a turned ankle. The Centers for Disease Control and Prevention (CDC) reports falls are the leading cause of injury and death from injury among people 65 and older. About three million seniors visit the emergency room due to falls every year.

The good news? There are simple steps you can take to reduce your risk of falling. It’s about increasing balance and stability.

“While the risk of falls increases as we age, it’s not inevitable,” said Dina Sexton, a national trainer for SilverSneakers, the nation’s leading fitness and well-being improvement program for seniors. “There are many simple, customizable exercises that can reduce the risk of falls. A steady sense of balance is the key.”

For those 65+, the right health plan can provide benefits to improve balance and prevent falls. According to a recent study by Tivity Health, a leading provider of health and wellness solutions, including SilverSneakers, 22% of Medicare Advantage beneficiaries report having fallen in the past year compared to 26% in traditional Medicare. Those who participate in SilverSneakers report the fewest falls at 14%. SilverSneakers members are also less likely to feel unsteady when standing or walking and are less worried about falling.

Almost all physical activity helps lower the risk of falls. Movement of any kind improves body awareness, helps build bone density and even increases muscle mass. Falls happen most often while you’re doing something mundane — going down a flight of stairs, changing a lightbulb, or walking on a slippery floor. That’s why it’s important to focus on “functional training,” which helps strengthen your body for everyday activities, said Sexton.

What’s functional training? It’s an exercise designed to mimic the types of movements you do in everyday life, like squatting, lifting, stepping up and down, balancing, walking, reaching above your head and more.

These types of moves require multiple muscle groups to work together, boosting coordination and allowing you to move in different planes of motion — from side to side and back and forth. Doing this helps improve joint health, and it gives you a better understanding of the way you move in general. Put another way, it gives people the strength and stability needed to avoid falls and ultimately to live independently.

Here are a few exercises you can do at home to help avoid falls. But before you do, consult a doctor for their advice and recommendations.

Sit-to-stand

Difficulty getting up and down from things like a dining room chair or a toilet seat can cause you to feel unsteady, which contributes to falls.

• Sit on a sturdy chair of standard height. Have a support in front of you, like the kitchen table or a countertop, to use if you feel unsteady.
• Lean forward and squeeze your gluteal muscles to stand up. The goal is to not use your hands.
• Repeat 10 times.

Balance exercises

Balance is the key to stability. Practice your balance this way:

• Stand by your kitchen counter or in a corner, so you’ll have something to reach out to if you lose your balance.
• Move your feet apart, shoulder width. Hold that pose steady, without swaying, for 10 seconds with your eyes open. Work your way up to 30 seconds.
• When you can hold that pose for 30 seconds without swaying, do the same with your feet together.
• When you feel confident with your feet together, do the same on one foot, then the other.
• When you’re confident with those poses, do them all with your eyes closed.

Heel raise

Heel raises can strengthen your calf and thigh muscles, improving balance and flexibility.

• Stand in front of your kitchen counter or by a sturdy kitchen chair with your feet flat on the floor, shoulder-width apart.
• Lift both heels off the floor, so you’re standing on the balls of your feet.
• Lower your heels so your feet are flat.
• Repeat 10-15 times.

The key to these exercises, said Sexton, is to do them consistently. A few minutes a day will make a big difference in your balance, flexibility and strength.

Tivity Health, through its flagship brand SilverSneakers, is the nation’s leading community fitness and well-being improvement program that helps eligible Medicare Advantage members stay physically active, socially engaged and mentally sharp. The program includes a fitness center membership and virtual classes that foster social interaction among members and encourage them to live healthy, active lifestyles. The program is available to more than 19 million Americans through many Medicare Advantage plans, Medicare Supplement carriers and group retiree plans.

With the right Medicare Advantage plan, joining a senior fitness program is easy. And, with over 30 years of experience serving the senior population and offering classes for every fitness level, it’s an excellent way to get fit, stay engaged, reduce falls and be healthy. If you aren’t currently on an MA plan, the annual Medicare Enrollment Period between Oct. 15 and Dec. 7 is a perfect time to review plans and find one that includes SilverSneakers. Visit silversneakers.com to learn more.

2024-10-22T11:01:00

(BPT) – The word “cancer” can immediately turn someone’s world upside down. The six-letter word has the power to bring a flood of emotions with it – fear, anxiety and confusion. But learning about common symptoms to watch for and the impact of different types of cancer can help bring understanding and preparedness. That’s why Michael, an Ohio native living with an aggressive blood cancer known as diffuse large B-cell lymphoma (DLBCL), wants to share his story.

What to Know About This Type of Lymphoma

DLBCL is a type of aggressive, fast-growing non-Hodgkin’s lymphoma (NHL), a cancer that develops in the lymphatic system and affects B cells, a type of white blood cell.^[1],[2] DLBCL is the most common subtype of NHL, with more than 18,000 people being diagnosed with this type of cancer each year in the U.S.^[3] While DLBCL can occur at various ages, it is most frequently diagnosed among people aged 65-74.^[4] The symptoms associated with DLBCL often resemble those of more common conditions, such as: enlarged lymph nodes, painless swelling in the neck, underarms or groin; unexplained weight loss; fatigue and/or lack of energy; and chills, fever and/or excessive sweating, often at night.^[5],[6]

Despite being labeled as an “aggressive” cancer, DLBCL is curable for some.^[7] However, about 30-40% of people with DLBCL develop relapsed or refractory (R/R) disease,^[8] which means their cancer returns after initial treatments and/or their cancer stops responding to treatment.

People with R/R DLBCL experience significant treatment challenges, with outcomes worsening with each line of treatment.^[9] The heartbreaking reality is that 1 in 3 patients will not survive 5 years after receiving a DLBCL diagnosis.^[10]

How Michael Still Lives Life on His Own Terms

Michael, a 66-year-old, received the devastating diagnosis of DLBCL in 2016. He had coached softball and football for 32 years and loved being involved in his community, which had to be put on pause. Living with DLBCL can be difficult, especially for those who enjoy outdoor activities, as the disease can cause fatigue and/or lack of energy.

Adjusting to life with DLBCL can be hard, but thinking about how this would affect his children was even harder. “Not knowing if you have a tomorrow is a very unpleasant thing, and not knowing if you’ll be there for your family is even worse,” Michael shared. But he was able to push forward and finish treatment, driven by the desire to be there for his family and community. For five years, Michael was in remission.

In 2021, Michael’s cancer returned. He had gone through various treatments for his initial diagnosis already, including chemotherapy and radiation. But this time was different, and Michael would try several additional treatment options such as chemoimmunotherapy, CAR T therapy and a clinical trial.

Michael was also remarried now and had Kimberly in his life. Michael and Kimberly connected in 2018 after Kimberly came to watch her granddaughter’s soccer game that Michael was coaching. They fell in love and got married 6 months later. Kimberly became Michael’s Care Partner – a term used to refer to a “caregiver” who provides someone with physical and emotional support – and has been by his side for all aspects of his cancer treatment.

“Kimberly is a true blessing,” Michael said. “She is an absolute rock.” Kimberly acknowledged that Michael’s life with DLBCL had been challenging, but that they had many reasons to maintain hope. Her advice to others is to “think of treatments like water stations in a marathon: something may not be working, or may not work long term, but there can be something else ahead. Your health is not a sprint. It’s a marathon.” As it turned out, Michael was arriving at his next water station. He and his physician decided to try a bispecific antibody treatment known as EPKINLY^® (epcoritamab-bysp) following his relapse.

Michael began treatment with EPKINLY in May 2023, and has been on it since. EPKINLY is the first and only subcutaneous bispecific antibody approved by the U.S. Food and Drug Administration to treat adults with certain types of DLBCL and high-grade B-cell lymphoma that has come back or that did not respond to previous treatment after receiving two or more treatments.^[11] Treatment options are expanding, and EPKINLY offers a subcutaneous (just under the skin) injection option for patients living with this type of cancer.

Michael, along with his clinicians, noticed that he was responding to treatment well and said he is now in “a good place.” He enjoys every day he is able to spend time with Kimberly, his six daughters, and 10 grandchildren. Although Michael is still living with DLBCL, he shared that EPKINLY is helping to keep it under control – his bloodwork is normal, and his disease is stable. Michael’s physician also advised him to look out for certain signs and symptoms of infection during his treatment.

Michael’s journey with relapsed DLBCL has been ongoing for almost a decade, but with his support system and continued treatment with EPKINLY, Michael’s marathon continues.

What is EPKINLY?
EPKINLY is a prescription medicine used to treat adults with certain types of diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma that has come back or that did not respond to previous treatment after receiving 2 or more treatments. EPKINLY is approved based on patient response data. A study is ongoing to confirm the clinical benefit of EPKINLY. It is not known if EPKINLY is safe and effective in children.

IMPORTANT SAFETY INFORMATION

Important Warnings—EPKINLY can cause serious side effects, including:

• Cytokine release syndrome (CRS), which is common during treatment with EPKINLY and can be serious or life-threatening. To help reduce your risk of CRS, you will receive EPKINLY on a step-up dosing schedule (when you receive 2 smaller step-up doses of EPKINLY before your first full dose during your first cycle of treatment), and you may also receive other medicines before and for 3 days after receiving EPKINLY. Your first full dose of EPKINLY will be given on day 15 of your first cycle of treatment and you should be hospitalized for 24 hours after due to the risk of CRS and neurologic problems. If your dose of EPKINLY is delayed for any reason, you may need to repeat the step-up dosing schedule.
• Neurologic problems that can be life-threatening and lead to death. Neurologic problems may happen days or weeks after you receive EPKINLY.

Tell your healthcare provider or get medical help right away if you develop a fever of 100.4°F (38°C) or higher; dizziness or lightheadedness; trouble breathing; chills; fast heartbeat; feeling anxious; headache; confusion; shaking (tremors); problems with balance and movement, such as trouble walking; trouble speaking or writing; confusion and disorientation; drowsiness, tiredness or lack of energy; muscle weakness; seizures; or memory loss. These may be symptoms of CRS or neurologic problems. If you have any symptoms that impair consciousness, do not drive or use heavy machinery or do other dangerous activities until your symptoms go away.

EPKINLY can cause other serious side effects, including:

• Infections that may lead to death. Your healthcare provider will check you for signs and symptoms of infection before and during treatment and treat you as needed if you develop an infection. You should receive medicines from your healthcare provider before you start treatment to help prevent infection. Tell your healthcare provider right away if you develop any symptoms of infection during treatment, including fever of 100.4°F (38°C) or higher, cough, chest pain, tiredness, shortness of breath, painful rash, sore throat, pain during urination, or feeling weak or generally unwell.
• Low blood cell counts, which can be serious or severe. Your healthcare provider will check your blood cell counts during treatment. EPKINLY may cause low blood cell counts, including low white blood cells (neutropenia), which can increase your risk for infection; low red blood cells (anemia), which can cause tiredness and shortness of breath; and low platelets (thrombocytopenia), which can cause bruising or bleeding problems.

Your healthcare provider will monitor you for symptoms of CRS, neurologic problems, infections, and low blood cell counts during treatment with EPKINLY. Your healthcare provider may temporarily stop or completely stop treatment with EPKINLY if you develop certain side effects.

Before you receive EPKINLY, tell your healthcare provider about all your medical conditions, including if you have an infection, are pregnant or plan to become pregnant, or are breastfeeding or plan to breastfeed. If you receive EPKINLY while pregnant, it may harm your unborn baby. If you are a female who can become pregnant, your healthcare provider should do a pregnancy test before you start treatment with EPKINLY and you should use effective birth control (contraception) during treatment and for 4 months after your last dose of EPKINLY. Tell your healthcare provider if you become pregnant or think that you may be pregnant during treatment with EPKINLY. Do not breastfeed during treatment with EPKINLY and for 4 months after your last dose of EPKINLY.

The most common side effects of EPKINLY include CRS, tiredness, muscle and bone pain, injection site reactions, fever, stomach-area (abdominal) pain, nausea, and diarrhea. The most common severe abnormal laboratory test results include decreased white blood cells, decreased red blood cells, and decreased platelets.

These are not all of the possible side effects of EPKINLY. Call your doctor for medical advice about side effects. You are encouraged to report side effects to the FDA at (800) FDA-1088 or www.fda.gov/medwatch or to Genmab US, Inc. at 1-855-4GENMAB (1-855-443-6622).

Please see Medication Guide, including Important Warnings.

Please click to see Important Facts about EPKINLY, including Important Warnings for cytokine release syndrome and neurologic problems.

If you or someone you know has R/R DLBCL, speak with your doctor about potential therapies, including EPKINLY.

For more information, please visit epkinly.com.

COM-US-EPK-0001012

2024-10-16T11:01:01

(BPT) – Kathy was only in her sixties when she was diagnosed with low-grade upper tract urothelial cancer (LG-UTUC). It came as a complete surprise given she was young, exercised every day, ate right, and did everything else she could to keep herself healthy.

Cancer came calling anyway, and a rare form at that. Most patients who are diagnosed with urothelial cancers develop tumors in the lower tract, with only 5% to 10% having tumors in the upper tract,¹ like Kathy’s. And none of the existing treatment options for LG-UTUC were appealing to Kathy or her family.

Treatment meant either removing her kidney and ureter, the tube connecting the kidney to the bladder, or having a cystoscopy to remove the tumors, along with ongoing tests and scans after the procedure to monitor for a recurrence. After discussing it with her husband, Kathy chose to keep her kidney and endure those procedures. But it wasn’t a durable solution.

“We agreed to keep going back in to check for recurrences,” said Stephen Bennett, MD, the Urology Group in Cincinnati, Ohio, Kathy’s doctor. “The next six or seven times we went back in after a procedure, there was a recurrence. Every single time.”

The cycle of removing the tumors, recurrence, followed by another painful procedure to remove those tumors, went on for years. But Dr. Bennett knew JELMYTO^® (mitomycin) for pyelocalyceal solution, a drug not yet approved by the FDA at that time, could potentially be another treatment option for low-grade upper tract urothelial cancer that could benefit Kathy. He encouraged Kathy to continue her current treatment plan and wait a little longer before removing the kidney, in hopes the drug’s approval would come soon. And it did!

JELMYTO: A breakthrough in LG-UTUC treatment

That day came. In 2020 JELMYTO became the first FDA-approved therapy treatment for LG-UTUC in adult patients.² JELMYTO is instilled in a procedure that spares the kidney.

“After JELMYTO was approved, we signed her up,” Dr. Bennett said.

“I didn’t even have to think about it,” Kathy said. “I was going to do it.”

JELMYTO combines mitomycin (chemo) with sterile hydrogel, a proprietary reverse-thermal technology (RTGel^®) that allows the medicine to transform from a chilled liquid at instillation into a gel at body temperature. It is injected directly into the kidney via a catheter or a small port, and delivers treatment exactly where it is needed, not where it isn’t. This completes the primary treatment regimen for patients with low-grade UTUC, even those with endoscopically unreachable tumors, because it delivers chemoblative therapy directly to the upper tract.

JELMYTO stays in a kidney for four to six hours, fighting the tumors. Then, it slowly starts to liquify and naturally leaves your body when you urinate.

A clinical study called OLYMPUS followed adults who were in different stages of their journey with low-grade UTUC. Some were newly diagnosed, and over half had been treated for low-grade UTUC in the past. Some had very hard-to-reach tumors that could not be removed with endoscopic management. The findings showed that three months following initiation of treatment, 58% of participants had their tumors disappear after a once-a-week for six weeks treatment plan with JELMYTO.³ The most common side effects observed in OLYMPUS included urinary tract infection, blood in your urine, side pain, nausea, trouble with urination, kidney problems, vomiting, tiredness, stomach (abdomen) pain.

She received JELYMTO once a week for six weeks in an outpatient procedure. The results surprised even her doctor.

“After Kathy’s six rounds of treatment we waited six to eight weeks and we did the same cystoscopy and ureteroscopy that we had done many times before,” said Dr. Bennett. Fortunately, in Kathy’s case, Dr. Bennett saw no evidence of recurrence.

Six months later, Kathy went back to Dr. Bennett for a follow-up. No recurrence. Six months after that, still clear.

“It has changed my life as far as doing more things with the family,” Kathy said. “I’m looking forward to seeing my grandchildren grow up, enjoying life. It is a weight off of everybody’s mind. So that was the best part.” This treatment option had a positive impact on her life. To see more of Kathy’s story, visit: https://www.jelmyto.com/hcp/resources/video-library/.

Others with similar stories of frequent recurrence who do not wish to remove their kidney should consult their doctor about all their treatment options, including JELMYTO. For more information about JELMYTO, including access to a dedicated team of support throughout the coordination process, visit https://www.jelmyto.com/patient/ and talk to your doctor.

APPROVED USE FOR JELMYTO

JELMYTO® is a prescription medicine used to treat adults with a type of cancer of the lining of the upper urinary tract including the kidney called low-grade Upper Tract Urothelial Cancer (LG-UTUC).

IMPORTANT SAFETY INFORMATION

You should not receive JELMYTO if you have a hole or tear (perforation) of your bladder or upper urinary tract.

Before receiving JELMYTO, tell your healthcare provider about all your medical conditions, including if you:

• are pregnant or plan to become pregnant. JELMYTO can harm your unborn baby. You should not become pregnant during treatment with JELMYTO. Tell your healthcare provider right away if you become pregnant or think you may be pregnant during treatment with JELMYTO. Females who are able to become pregnant: You should use effective birth control (contraception) during treatment with JELMYTO and for 6 months after the last dose. Males being treated with JELMYTO: If you have a female partner who is able to become pregnant, you should use effective birth control (contraception) during treatment with JELMYTO and for 3 months after the last dose.
• are breastfeeding or plan to breastfeed. It is not known if JELMYTO passes into your breast milk. Do not breastfeed during treatment with JELMYTO and for 1 week after the last dose.
• Tell your healthcare provider if you take water pills (diuretic).

How will I receive JELMYTO?

• Your healthcare provider will tell you to take a medicine called sodium bicarbonate before each JELMYTO treatment.
• You will receive your JELMYTO dose from your healthcare provider 1 time a week for 6 weeks. It is important that you receive all 6 doses of JELMYTO according to your healthcare provider’s instructions. If you miss any appointments, call your healthcare provider as soon as possible to reschedule your appointment. Your healthcare provider may recommend up to an additional 11 monthly doses.
• JELMYTO is given to your kidney through a tube called a catheter.
• During treatment with JELMYTO, your healthcare provider may tell you to take additional medicines or change how you take your current medicines.

After receiving JELMYTO:

• JELMYTO may cause your urine color to change to a violet to blue color. Avoid contact between your skin and urine for at least 6 hours.
• To urinate, males and females should sit on a toilet and flush the toilet several times after you use it. After going to the bathroom, wash your hands, your inner thighs, and genital area well with soap and water.
• Clothing that comes in contact with urine should be washed right away and washed separately from other clothing.

JELMYTO may cause serious side effects, including:

• Swelling and narrowing of the tube that carries urine from the kidney to the bladder (ureteric obstruction). If you develop swelling and narrowing, and to protect your kidney from damage, your healthcare provider may recommend the placement of a small plastic tube (stent) in the ureter to help the kidney drain. Tell your healthcare provider right away if you develop side pain or fever during treatment with JELMYTO.
• Bone marrow problems. JELMYTO can affect your bone marrow and can cause a decrease in your white blood cell, red blood cell, and platelet counts. Your healthcare provider will do blood tests prior to each treatment to check your blood cell counts during treatment with JELMYTO. Your healthcare provider may need to temporarily or permanently stop JELMYTO if you develop bone marrow problems during treatment with JELMYTO.
• The most common side effects of JELMYTO include: urinary tract infection, blood in your urine, side pain, nausea, trouble with urination, kidney problems, vomiting, tiredness, stomach (abdomen) pain.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. You may also report side effects to UroGen Pharma at 1-855-987-6436.

Please visit www.jelmyto.com and see JELMYTO Full Prescribing Information, including the Patient Information, for additional information.

2024-10-16T05:01:00

(BPT) – Pickleball is the fastest-growing sport in the country, with many seniors roaring onto pickleball courts nationwide. But whether it’s a friendly game or an intramural matchup, all senses must be engaged for the best play — especially our hearing.

Think about the last time you had your hearing tested. Was it recently? If it wasn’t and you find yourself turning up the television or straining to hear conversations in crowded rooms, it’s time to have an audiologist or hearing instrument specialist check your hearing.

According to the National Council on Aging (NCOA), hearing loss affects more than 60 million Americans ages 12 and older. By the time people reach age 65, more than 30% experience hearing loss, and that percentage only goes up as people age. The NCOA also reports nearly 30 million Americans could significantly benefit from wearing a hearing aid.

HearingLife + USA Pickleball

That’s why HearingLife, a global leader in hearing care, has become USA Pickleball’s official hearing care partner to raise awareness about the importance of hearing health and the dangers of hearing loss. HearingLife knows that participating in an active lifestyle — like a pickleball match — encourages an all-around healthy routine, including hearing care.

At select USA Pickleball events throughout the year, HearingLife is offering complimentary hearing assessments to attendees and players.

“Hearing loss can prevent people from doing activities they love, like pickleball,” said Dr. Leslie Soiles, HearingLife’s chief audiologist. “And it’s ironic because these types of activities and exercises can actually help slow hearing loss. That’s why getting your hearing checked is so important. It’s a gateway to a more active, fulfilling life.”

In addition to offering on-site services such as free screenings, HearingLife’s presence will include educational resources on how hearing loss can impact not only athletic performance, but also overall quality of life. Visitors can also learn about the latest advancements in hearing aid technology, including devices that are designed to enhance clarity in noisy environments — perfect for sporting activities like pickleball.

The risk of untreated hearing loss

Many people brush off hearing loss and don’t think about hearing as essential to health and longevity. Untreated hearing loss can lead to social isolation, loneliness, social withdrawal and even problems at work if you miss instructions or don’t understand coworkers. Worse, it can cause cognitive decline, memory problems and even increased risk of falls.

Caring for your hearing

You care for your teeth by brushing twice each day and for your body by eating right and exercising. What about your ears? Here are some ways to care for your hearing, from the pros at HearingLife.

1. Mind your exposure to loud noises. Loved those packed concerts in your youth? We did, too. For the reunion tour, it’s wise to wear earplugs. That also goes for exposure to construction sites or loud machinery.

2. Monitor how long you wear headphones or earbuds. Turn down the volume of your favorite podcast or playlist, and don’t wear the ear devices for an extended period of time.

3. Get regular checkups. Visit your hearing care professional on a regular basis, especially if you notice worsening hearing loss or other symptoms such as ringing in your ears.

4. Manage chronic conditions. High blood pressure, diabetes and smoking can contribute to hearing loss. Managing those conditions and quitting smoking helps keep your ears healthy.

5. Keep active. The improved blood flow you get from exercise is great for your ears. Walking, cycling, canoeing, working out at the gym, all contribute to good hearing health. Why not take up pickleball?

HearingLife is making it easy to get started. The company is sponsoring a giveaway to the USA Pickleball National Championships! One lucky winner and a plus-one can enter for a chance to win a three-night trip to Mesa, AZ, for the USA Pickleball tournament taking place Nov. 9-17. It’s free and easy to enter: just visit https://www.hearinglife.com/pickleball-sweepstakes and submit your email. The winner will be notified on Oct. 23.

2024-10-10T14:35:00

(BPT) – COVID-19 can affect anyone, so it’s important to stay informed as we approach another respiratory virus season. This infographic offers key insights on COVID-19 vaccinations, transmission, increased risk factors, Long COVID risks, and the benefits of getting your flu shot at the same time. It also explains when and how to get your updated vaccine for the year. Always talk to your doctor if you have any questions or concerns about vaccinations this season. To find your local vaccine availability and COVID-19 resources, please visit: https://www.ForYouAndThem.com/.